VAR 10-Q Quarterly Report March 30, 2018 | Alphaminr
VARIAN MEDICAL SYSTEMS INC

VAR 10-Q Quarter ended March 30, 2018

VARIAN MEDICAL SYSTEMS INC
10-Ks and 10-Qs
10-Q
Quarter ended Jan. 1, 2021
10-K
Fiscal year ended Oct. 2, 2020
10-Q
Quarter ended July 3, 2020
10-Q
Quarter ended April 3, 2020
10-Q
Quarter ended Jan. 3, 2020
10-K
Fiscal year ended Sept. 27, 2019
10-Q
Quarter ended June 28, 2019
10-Q
Quarter ended March 29, 2019
10-Q
Quarter ended Dec. 28, 2018
10-K
Fiscal year ended Sept. 28, 2018
10-Q
Quarter ended June 29, 2018
10-Q
Quarter ended March 30, 2018
10-Q
Quarter ended Dec. 29, 2017
10-K
Fiscal year ended Sept. 29, 2017
10-Q
Quarter ended June 30, 2017
10-Q
Quarter ended March 31, 2017
10-Q
Quarter ended Dec. 30, 2016
10-K
Fiscal year ended Sept. 30, 2016
10-Q
Quarter ended July 1, 2016
10-Q
Quarter ended April 1, 2016
10-Q
Quarter ended Jan. 1, 2016
10-K
Fiscal year ended Oct. 2, 2015
10-Q
Quarter ended July 3, 2015
10-Q
Quarter ended April 3, 2015
10-Q
Quarter ended Jan. 2, 2015
10-K
Fiscal year ended Sept. 26, 2014
10-Q
Quarter ended June 27, 2014
10-Q
Quarter ended March 28, 2014
10-Q
Quarter ended Dec. 27, 2013
10-K
Fiscal year ended Sept. 27, 2013
10-Q
Quarter ended June 28, 2013
10-Q
Quarter ended March 29, 2013
10-Q
Quarter ended Dec. 28, 2012
10-K
Fiscal year ended Sept. 28, 2012
10-Q
Quarter ended June 29, 2012
10-Q
Quarter ended March 30, 2012
10-Q
Quarter ended Dec. 30, 2011
10-K
Fiscal year ended Sept. 30, 2011
10-Q
Quarter ended July 1, 2011
10-Q
Quarter ended April 1, 2011
10-Q
Quarter ended Dec. 31, 2010
10-K
Fiscal year ended Oct. 1, 2010
10-Q
Quarter ended July 2, 2010
10-Q
Quarter ended April 2, 2010
10-Q
Quarter ended Jan. 1, 2010
PROXIES
DEF 14A
Filed on Dec. 20, 2019
DEF 14A
Filed on Dec. 21, 2018
DEF 14A
Filed on Dec. 29, 2017
DEF 14A
Filed on Dec. 30, 2016
DEF 14A
Filed on Dec. 30, 2015
DEF 14A
Filed on Dec. 30, 2014
DEF 14A
Filed on Jan. 6, 2014
DEF 14A
Filed on Dec. 28, 2012
DEF 14A
Filed on Dec. 28, 2011
DEF 14A
Filed on Dec. 29, 2010
TABLE OF CONTENTS
Part IItem 1. Unaudited Financial StatementsNote 2, "discontinued Operations"Note 12, "income Taxes"Note 17, "segment Information"Note 16, "vpt Loans and Securities"Note 5, "fair Value"Note 9, "derivative Instruments and Hedging Activities"Note 6, "receivables"Note 3, "business Combinations"Note 18, "subsequent Events"Note 1, "summary Of Significant Accounting Policies"Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsNote 8, "borrowings"Note 13, "stockholders' Equity and Noncontrolling Interests"Note 10, "commitments and Contingencies"Item 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart IIItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits

Exhibits

2.1 Scheme Implementation Deed dated January 30, 2018 between Varian Medical Systems, Inc. and Sirtex Medical Limited (incorporated by reference to Exhibit No. 2.1 to the Registrant's Form 10-Q Quarterly Report for the quarter ended December 29, 2017, File No. 1-7598). 10.1 Credit Agreement, dated as of April 3, 2018, among the Registrant, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer and each lender from time to time party thereto (incorporated by reference to Exhibit No. 10.1 to the Registrants Form 8-K Current Report filed as of April 4, 2018, File No. 1-7598). 15.1* Letter Regarding Unaudited Interim Financial Information. 31.1* Chief Executive Officer Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act. 31.2* Chief Financial Officer Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act. 32.1* Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2* Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.